日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Realization of High-Power Single-Frequency Continuous-Wave Tunable 689 nm Laser

实现高功率单频连续波可调谐689nm激光器

Wei, Jiao; Qiao, Jingru; Jin, Pixian; Su, Jing; Lu, Huadong

High-Power Single-Frequency Continuous-Wave Tunable 1064/532 nm Dual-Wavelength Laser

高功率单频连续波可调谐1064/532 nm双波长激光器

Peng, Weina; Jin, Pixian; Su, Jing; Wei, Jiao; Lu, Huadong

Targeting endothelial coagulation signaling ameliorates liver obstructive cholestasis and dysfunctional angiogenesis

靶向内皮凝血信号可改善肝脏阻塞性胆汁淤积和功能障碍的血管生成

Xue Yang, Yangying Ou, Ying Yang, Lu Wang, Yuwei Zhang, Fulan Zhao, Pixian Shui, Jie Qing

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma

CDC6是一种预后生物标志物,与胶质瘤中的免疫浸润相关。

Wang, Feng; Zhao, Fen; Zhang, Li; Xiong, Lai; Mao, Qing; Liu, Yanhui; Qiu, Xiaoguang; Wang, Xiang; Shui, Lin; Chen, Xi; Ren, Kexing; Shui, Pixian; Zhang, Qiongwen; Deng, Yifei; Li, Weimin; Xie, Xiaoqi; Wu, Dengbin; Li, Tao; Lang, Jinyi; Liu, Lei; Chen, Huaying; Xu, Jianguo; Bai, Sen; Li, Zhiping; Yue, Qiang; Chen, Ni; Zhou, Bingwen; Yi, Cheng; Wei, Yuquan; Fu, Yuchuan; Luo, Yong; Gou, Qiheng; Liu, Lunxu; Liu, Yuanzhao; Kang, Jingbo; Wang, Junjie; Jing, Dongcun; Zhang, Fuquan; Yang, Xiaoyan; Li, Xianfeng; Jiang, Tao; Zhang, Zongcun; Zhou, Yizhi; Yi, Junlin

Targeted inhibition of the immunoproteasome blocks endothelial MHC class II antigen presentation to CD4+ T cells in chronic liver injury

靶向抑制免疫蛋白酶体可阻断慢性肝损伤中内皮 MHC II 类抗原呈递至 CD4+ T 细胞

Yuwei Zhang, Xue Yang, Tao Bi, Xia Wu, Lu Wang, Yafeng Ren, Yangying Ou, Chengliang Xie, Kuangjie Li, Haolong Ran, Jing Wang, Fulan Zhao, Pixian Shui, Jie Qing

Performance Improvement of Single-Frequency CW Laser Using a Temperature Controller Based on Machine Learning

基于机器学习的温度控制器对单频连续波激光器性能的提升

Qiao, Haoming; Peng, Weina; Jin, Pixian; Su, Jing; Lu, Huadong

A Review of the High-Power All-Solid-State Single-Frequency Continuous-Wave Laser

高功率全固态单频连续波激光器综述

Peng, Weina; Jin, Pixian; Li, Fengqin; Su, Jing; Lu, Huadong; Peng, Kunchi

Durable Response and Good Tolerance to the Triple Combination of Toripalimab, Gemcitabine, and Nab-Paclitaxel in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma

转移性胰腺导管腺癌患者接受托瑞普利单抗、吉西他滨和白蛋白紫杉醇三联疗法后,疗效持久且耐受性良好

Shui, Lin; Cheng, Ke; Li, Xiaofen; Shui, Pixian; Li, Shuangshuang; Peng, Yang; Li, Jian; Guo, Fengzhu; Yi, Cheng; Cao, Dan

Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma

一项开放标签、单臂、Ib/II期研究方案,旨在评估托瑞普利单抗、白蛋白紫杉醇和吉西他滨联合方案作为不可切除胰腺导管腺癌患者一线治疗的疗效。

Shui, Lin; Cheng, Ke; Li, Xiaofen; Shui, Pixian; Zhou, Xiaohan; Li, Jian; Yi, Cheng; Cao, Dan

The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology

放射基因组学在精准医学中的时代:一种支持肿瘤诊断、治疗决策和预后的新兴方法

Shui, Lin; Ren, Haoyu; Yang, Xi; Li, Jian; Chen, Ziwei; Yi, Cheng; Zhu, Hong; Shui, Pixian